| Name | las191859 |
|---|
| Description | LAS191859 is an orally active, potent and selective CRTh2 antagonist with an IC50 of 9.58 nM against human CRTh2. LAS191859 can be used for the research of chronic asthma[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 7.6 nM (guinea pig CRTh2), 9.58 nM (human CRTh2), 14 nM (rat CRTh2), 15.5 nM (mouse CRTh2)[1] |
| References |
| Molecular Formula | C24H24F3N3O3 |
|---|---|
| Molecular Weight | 459.46 |